{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "179.55",
    "chg": -1,
    "chgp": "-0.55%",
    "dir": -1,
    "prev_price": "180.55",
    "mcapval": "23,866.65 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DK501011",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "18.34 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.177.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3748654",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3748654.png",
        "date": "2025-12-05 10:11:54",
        "description": "Piramal Pharma's shares touched a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.177.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3748655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3748655.png",
        "date": "2025-12-05 10:11:50",
        "description": "Piramal Pharma's shares reached a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.177.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amid-continued-downtrend-3748650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3748650.png",
        "date": "2025-12-05 10:11:50",
        "description": "Piramal Pharma's shares touched a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Stock Hits 52-Week Low at Rs.177.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3748653",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3748653.png",
        "date": "2025-12-05 10:11:45",
        "description": "Piramal Pharma's shares touched a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a three-day losing streak that has seen the stock fall by 3.59%. This performance contrasts sharply with the broader market, where the Sensex closed marginally higher, underscoring the stock's ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.180.1 Amidst Weak Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3746785",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3746785.png",
        "date": "2025-12-04 12:49:17",
        "description": "Piramal Pharma’s shares touched a fresh 52-week low of Rs.180.1 today, marking a significant decline amid subdued financial performance and persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about profitability and debt servicing capacity."
      },
      {
        "title": "Is Piramal Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-piramal-pharma-technically-bullish-or-bearish-3745705",
        "imagepath": "",
        "date": "2025-12-04 08:48:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Shift and Momentum Indicators</strong></p>\n<p>As of 3 December 2025, Piramal Pharma's technical trend has shifted from mildly bearish to outright bearish. This change reflects a growing consensus among technical tools that the stock is facing sustained selling pressure. The Moving Average Convergence Divergence (MACD) indicator, a widely used momentum oscillator, shows a bearish signal on the weekly chart and remains mildly bearish on the monthly timeframe. This suggests that short-term momentum is weakening more sharply than longer-term trends, which still show some residual caution but no clear bullish reversal.</p>\n<p>The Relative Strength Index (RSI), often used to identify overbought or oversold conditions, currently provides no clear signal on either weekly or monthly c..."
      },
      {
        "title": "Piramal Pharma Technical Momentum Shifts Amid Bearish Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-technicals-turn-bearish-amid-steep-price-decline-3745546",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_technicaldot_3745546.png",
        "date": "2025-12-04 08:12:40",
        "description": "Piramal Pharma's stock price momentum has shifted towards a more bearish technical outlook, reflecting a series of signals from key indicators such as MACD, RSI, and moving averages. The pharmaceutical and biotechnology company’s recent price action and technical parameters suggest a cautious stance for investors amid broader market dynamics."
      },
      {
        "title": "How has been the historical performance of Piramal Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-piramal-pharma-3744786",
        "imagepath": "",
        "date": "2025-12-03 22:57:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the last four fiscal years, Piramal Pharma’s net sales have shown consistent growth, rising from ₹6,559 crore in March 2022 to ₹9,151 crore by March 2025. This represents a compound annual growth rate (CAGR) of approximately 11.5%, reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this trend, with no other operating income reported, indicating that core business activities have driven revenue growth.</p>\n<p>Operating profit before other income (PBDIT) exhibited volatility, with a dip in March 2023 to ₹628 crore from ₹950 crore in March 2022, before rebounding strongly to ₹1,445 crore in March 2025. The operating profit margin excluding other income improved from 14.48% in 2022 to 15...."
      },
      {
        "title": "Piramal Pharma Sees Revision in Market Evaluation Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-downgraded-to-strong-sell-by-marketsmojo-amid-weak-financials-3731545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PiramalPharma_mojoScore_3731545.png",
        "date": "2025-11-26 09:46:59",
        "description": "Piramal Pharma has undergone a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. The changes stem from a combination of factors including its current financial performance, valuation metrics, and technical indicators, all of which have influenced investor sentiment in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 348,
    "sid": "1003728",
    "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "19-Nov-2025",
      "details": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "07-Nov-2025",
      "details": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "06-Nov-2025",
      "details": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Piramal Pharma Stock Falls to 52-Week Low of Rs.177.6 Amidst Continued Downtrend

2025-12-05 10:11:54

Piramal Pharma's shares touched a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.177.6 Amidst Continued Downtrend

2025-12-05 10:11:50

Piramal Pharma's shares reached a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.177.6 Amidst Continued Downtrend

2025-12-05 10:11:50

Piramal Pharma's shares touched a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Stock Hits 52-Week Low at Rs.177.6 Amidst Continued Downtrend

2025-12-05 10:11:45

Piramal Pharma's shares touched a fresh 52-week low of Rs.177.6 today, marking a significant decline amid a three-day losing streak that has seen the stock fall by 3.59%. This performance contrasts sharply with the broader market, where the Sensex closed marginally higher, underscoring the stock's ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.180.1 Amidst Weak Financial Indicators

2025-12-04 12:49:17

Piramal Pharma’s shares touched a fresh 52-week low of Rs.180.1 today, marking a significant decline amid subdued financial performance and persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about profitability and debt servicing capacity.

Read More

Is Piramal Pharma technically bullish or bearish?

2025-12-04 08:48:43

Technical Trend Shift and Momentum Indicators

As of 3 December 2025, Piramal Pharma's technical trend has shifted from mildly bearish to outright bearish. This change reflects a growing consensus among technical tools that the stock is facing sustained selling pressure. The Moving Average Convergence Divergence (MACD) indicator, a widely used momentum oscillator, shows a bearish signal on the weekly chart and remains mildly bearish on the monthly timeframe. This suggests that short-term momentum is weakening more sharply than longer-term trends, which still show some residual caution but no clear bullish reversal.

The Relative Strength Index (RSI), often used to identify overbought or oversold conditions, currently provides no clear signal on either weekly or monthly c...

Read More

Piramal Pharma Technical Momentum Shifts Amid Bearish Indicators

2025-12-04 08:12:40

Piramal Pharma's stock price momentum has shifted towards a more bearish technical outlook, reflecting a series of signals from key indicators such as MACD, RSI, and moving averages. The pharmaceutical and biotechnology company’s recent price action and technical parameters suggest a cautious stance for investors amid broader market dynamics.

Read More

How has been the historical performance of Piramal Pharma?

2025-12-03 22:57:29

Revenue and Profitability Trends

Over the last four fiscal years, Piramal Pharma’s net sales have shown consistent growth, rising from ₹6,559 crore in March 2022 to ₹9,151 crore by March 2025. This represents a compound annual growth rate (CAGR) of approximately 11.5%, reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this trend, with no other operating income reported, indicating that core business activities have driven revenue growth.

Operating profit before other income (PBDIT) exhibited volatility, with a dip in March 2023 to ₹628 crore from ₹950 crore in March 2022, before rebounding strongly to ₹1,445 crore in March 2025. The operating profit margin excluding other income improved from 14.48% in 2022 to 15....

Read More

Piramal Pharma Sees Revision in Market Evaluation Amidst Challenging Financials

2025-11-26 09:46:59

Piramal Pharma has undergone a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. The changes stem from a combination of factors including its current financial performance, valuation metrics, and technical indicators, all of which have influenced investor sentiment in the Pharmaceuticals & Biotechnology sector.

Read More

View All News